CYCS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.398000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.255990E-01
Normal-vs-Stage2
2.557400E-01
Normal-vs-Stage3
5.574600E-01
Normal-vs-Stage4
3.604200E-02
Stage1-vs-Stage2
6.125800E-01
Stage1-vs-Stage3
2.630600E-01
Stage1-vs-Stage4
9.619800E-01
Stage2-vs-Stage3
4.313400E-01
Stage2-vs-Stage4
6.433200E-01
Stage3-vs-Stage4
1.935620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.581000E-01
Normal-vs-AfricanAmerican
6.012100E-02
Normal-vs-Asian
1.367430E-01
Caucasian-vs-AfricanAmerican
7.179000E-01
Caucasian-vs-Asian
9.648400E-01
AfricanAmerican-vs-Asian
6.952000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.825560E-01
Normal-vs-Female
3.094400E-01
Male-vs-Female
5.594400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.563000E-01
Normal-vs-Age(41-60Yrs)
2.386500E-04
Normal-vs-Age(61-80Yrs)
2.341200E-01
Normal-vs-Age(81-100Yrs)
1.671960E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.527800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.232600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.477800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.452240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.184600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.034600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.409800E-01
Normal-vs-Daily Drinker
2.746200E-01
Normal-vs-Weekly Drinker
7.498400E-02
Normal-vs-Occasional Drinker
1.506960E-01
Normal-vs-Social Drinker
3.901500E-02
Non Drinker-vs-Daily Drinker
5.912200E-01
Non Drinker-vs-Weekly Drinker
2.827800E-01
Non Drinker-vs-Occasional Drinker
1.146800E-01
Non Drinker-vs-Social Drinker
2.584600E-01
Daily Drinker-vs-Weekly Drinker
3.932000E-01
Daily Drinker-vs-Occasional Drinker
3.250800E-01
Daily Drinker-vs-Social Drinker
4.061400E-01
Weekly Drinker-vs-Occasional Drinker
7.203000E-01
Weekly Drinker-vs-Social Drinker
8.523400E-01
Occasional Drinker-vs-Social Drinker
8.437800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.519800E-01
Normal-vs-Grade 2
6.420600E-01
Normal-vs-Grade 3
6.373600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.499200E-01
Grade 1-vs-Grade 3
5.531800E-01
Grade 1-vs-Grade 4
6.519800E-01
Grade 2-vs-Grade 3
7.724200E-01
Grade 2-vs-Grade 4
6.420600E-01
Grade 3-vs-Grade 4
6.373600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.873000E-01
Normal-vs-NonDiabetic
2.648400E-01
Diabetic-vs-NonDiabetic
3.613600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.170000E-01
Normal-vs-NoPancreatitis
2.839000E-01
Pancreatitis-vs-NoPancreatitis
2.123800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.165430E-01
Normal-vs-N1
2.774200E-01
N0-vs-N1
9.123200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.953800E-04
Normal-vs-TP53-NonMutant
8.121300E-03
TP53-Mutant-vs-TP53-NonMutant
1.138550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
